Zealand Pharma
730.5
DKK
+0.07 %
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
18 following
+0.07%
-12.98%
-17.08%
+11.78%
+95.74%
+121.23%
+443.53%
+258.44%
+818.87%
www.zealandpharma.com
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
ZEAL
Daily low / high price
727.5 / 735.5
DKK
Market cap
51.88B DKK
Turnover
7.28M DKK
Volume
10K
Financial calendar
Annual report
2025-02-20
Interim report
2025-05-08
Interim report
2025-08-14
Interim report
2025-11-06
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Van Herk Investments | 16.8 % | 16.8 % |
| Credit Suisse Group AG | 6.2 % | 6.2 % |
ShowingAll content types
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools